SKIN(SKIN)
SKIN
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E |
|---|---|---|---|
| Revenue Avg | $290M | $305M | $313M |
| Low | $287M | $302M | $313M |
| High | $292M | $310M | $313M |
| EBITDA Avg | $-44M | $-46M | $-47M |
| Low | $-44M | $-47M | $-47M |
| High | $-43M | $-45M | $-47M |
| EBIT Avg | $-62M | $-66M | $-67M |
| Low | $-63M | $-67M | $-67M |
| High | $-62M | $-65M | $-67M |
| Net Income Avg | $-24M | $-9M | $-11M |
| Low | $-29M | $-20M | $-20M |
| High | $-9M | $4M | $772,409 |
| EPS Avg | $-0.16 | $-0.07 | $-0.09 |
| Low | $-0.22 | $-0.15 | $-0.15 |
| High | $-0.07 | $0.03 | $0.01 |
| Analysts (Rev / EPS) | 7 / 4 | 6 / 4 | 3 / 3 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $70M | $82M | $67M | $77M | $72M | $85M |
| Low | $68M | $80M | $66M | $75M | $71M | $83M |
| High | $71M | $84M | $69M | $79M | $74M | $87M |
| EBITDA Avg | $-10M | $-12M | $-10M | $-12M | $-11M | $-13M |
| Low | $-11M | $-13M | $-10M | $-12M | $-11M | $-13M |
| High | $-10M | $-12M | $-10M | $-11M | $-11M | $-12M |
| EBIT Avg | $-15M | $-18M | $-14M | $-17M | $-16M | $-18M |
| Low | $-15M | $-18M | $-15M | $-17M | $-16M | $-19M |
| High | $-15M | $-17M | $-14M | $-16M | $-15M | $-18M |
| Net Income Avg | $-7M | $-1M | $-7M | $-3M | $-6M | $-3M |
| Low | $-11M | $-2M | $-7M | $-3M | $-6M | $-3M |
| High | $-3M | $-1M | $-7M | $-3M | $-6M | $-3M |
| EPS Avg | $-0.05 | $-0.01 | $-0.05 | $-0.02 | $-0.04 | $-0.02 |
| Low | $-0.08 | $-0.01 | $-0.06 | $-0.02 | $-0.04 | $-0.02 |
| High | $-0.02 | $-0.01 | $-0.05 | $-0.02 | $-0.04 | $-0.02 |
| Analysts (Rev / EPS) | 6 / 5 | 5 / 1 | 3 / 1 | 3 / 1 | 3 / 1 | 3 / 1 |